74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis |
| |
| Authors: | Isabelle Delabaye Filip De Keyser the REMITRACT study group |
| |
| Affiliation: | (1) Department of Immunology, Schering-Plough nv, 73 Rue de Stalle, 1180 Brussels, Belgium;(2) Department of Rheumatology, Ghent University, Ghent University Hospital, De Pintelaan 185, B-9000 Ghent, Belgium;(3) 19 Avenue des Vieux Amis, 1410 Waterloo, Belgium |
| |
| Abstract: | Introduction The objective was to describe the prevalence, types, and predictors of adverse events (AEs) in rheumatoid arthritis (RA) patients treated with infliximab and methotrexate in a daily clinical setting. |
| |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ |
|
